FDS
MRNA icon

First Dallas Securities’s Moderna MRNA Stock Holding History

First Dallas Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,725
Closed -$210K – 167
2023
Q2 		$210K Sell
1,725
-1,300
-43% -$173K 0.12% 121
2023
Q1 		$465K Sell
3,025
-1,600
-35% -$264K 0.27% 82
2022
Q4 		$831K Buy
4,625
+2,750
+147% +$450K 0.5% 52
2022
Q3 		$222K Hold
1,875
– – 0.15% 103
2022
Q2 		$268K Hold
1,875
– – 0.18% 98
2022
Q1 		$323K Buy
1,875
+10
+0.5% +$1.68K 0.18% 99
2021
Q4 		$474K Sell
1,865
-50
-3% -$14.6K 0.31% 70
2021
Q3 		$737K Sell
1,915
-1,235
-39% -$455K 0.51% 57
2021
Q2 		$740K Buy
+3,150
New +$563K 0.49% 54

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

First Dallas Securities's MRNA Position: Q3 2023 in Review

First Dallas Securities sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,725 shares — an estimated $210K sold.

First Dallas Securities first reported a position in MRNA in Q2 2021 and held it in 9 quarters. The position peaked at $831K in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • First Dallas Securities reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • First Dallas Securities sold 1,725 Moderna shares in Q3 2023, an estimated $210K.
  • First Dallas Securities first reported a position in Moderna in Q2 2021 and held it in 9 quarters.
  • First Dallas Securities's Moderna position peaked at $831K in Q4 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on First Dallas Securities's 13F filing for Q3 2023, filed 14 Nov 2023.